• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Patient Recruitment for Special Populations

Patient Recruitment for Special Populations

February 23, 2015
CenterWatch Staff

Patient recruitment for clinical trials is one of the most important, yet underfunded, components of a clinical trial.

Moving forward on a clinical trial without a proper recruitment strategy is a gamble that certainly is not worth the risk. That risk becomes higher when you need to recruit a special population—factors that increase risk can include prevalence, nature of the disease state, number of sites, number of countries, patient profile and patient recruitment budget. Two specific special populations that require specialized strategies are pediatric and hospital-based recruitment.

Pediatric trials represent a complex area of drug development, and conducting trials involving children presents unique challenges compared to adult studies. According to the Forum on Child and Family Statistics, although children comprise one-quarter of the U.S. population, an analysis of ClinicalTrials.gov revealed more than 10 times as many adult trials were registered compared with pediatric trials. With the under-representation of children in research, it is vital that ongoing studies meet recruitment timelines. Due to the vulnerable nature of the target subjects, pediatric trials are implemented under heightened regulatory guidelines.

Medicines in development for children

Patient identification in the majority of pediatric studies is challenging, due to the availability of relatively small and finite patient populations as well as the complexities of parental involvement and family decision making. Protective parents rely on trustworthy physicians for guidance on whether or not their child should consider participating in a trial. In pediatric trials, the parent or guardian plays a crucial role in the decision to participate. This can be a difficult decision for any individual, but when that person is making the decision on behalf of a child, concerns over the potential risks of participation are multiplied significantly.

Recruiting for clinical trials that target children under age 18 requires having solutions for parents’ need for detailed information about the study; assistance with time away from work, other children and school; and reassurance from the study staff that their child is in good hands. Providing tools to support the site staff’s discussion with families, as well as the information for parents, is critical to enrollment success. Family-oriented compensation such as for childcare, transportation or meals during long visits also may affect the success of pediatric recruitment.

Managing recruitment in a hospital, Intensive Care Unit, clinic or similar setting also involves special considerations. It requires a detailed understanding of the patient flow within the particular institution. Hospital information systems (HIS) should be used to access routine patient care data to effectively identify potential trial participants. Once identified, information can be sent to study personnel quickly by email and/or text message. Many of the personnel in these settings rotate with shift changes and operate in a much different environment than a physician’s office.

It is important to identify all points of contact and ensure they all have knowledge of the study opportunity and have access to tools to make the study consenting and enrollment process as easy as possible. Utilizing tools such as educational DVDs can help explain study requirements to potential participants using a consistent message. Various other tools can be made available to site staff to maintain study awareness and allow quick access to study information. Patient consent and follow-up in hospital settings is made much more difficult by the frequent need for surrogate consent and post-discharge care by different physicians. Ensuring strong linkages exist between the investigator and post-discharge caregivers is critical. And relevant collateral for caregivers that explains the trial and the informed consent process, as well as post-discharge needs, also is critical.

It is essential to understand the importance of recruitment for any clinical trial, but when faced with the task of developing a strategy to enroll hard-to-recruit special populations, particular considerations of the population and the communication methods available must be addressed. Because pediatric and hospital-based clinical trials make up a smaller percentage of clinical research, the importance of meeting recruitment goals is heightened. Not all recruitment tactics are appropriate or will be successful, but specialized strategies can increase success. 

 

Ashley Tointon supports innovative, data-driven techniques to provide high-impact, cost-effective recruitment and retention programs. She has more than 18 years of patient recruitment and project management experience supporting clinical trials and the pharmaceutical industry. Email comments and suggestions to tointon@icloud.com

This article was reprinted from CWWeekly, a leading clinical research industry newsletter providing expanded analysis on breaking news, study leads, trial results and more. Subscribe »

Upcoming Events

  • 12Apr

    The Patient Playbook Webinar Series, Part 3 — Rethinking the Development of Participant-Centric Clinical Trial Technology

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

  • White House

    Trial Stakeholders Advise White House on Emergency Research Infrastructure

  • SurveywBlueBackground-360x240.png

    Stress Levels Continue to Climb in Healthcare Workforce, Survey Finds

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing